tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market
SVA
Sinovac Biotech
RESEARCH TOOLSreports
Want to see SVA full AI Analyst Report?

Sinovac Biotech (SVA) Ratios

137 Followers

Sinovac Biotech Ratios

SVA's free cash flow for Q1 2024 was $1.00. For the 2024 fiscal year, SVA's free cash flow was decreased by $ and operating cash flow was $-0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 4.59 4.59 10.31 11.11 6.18
Quick Ratio
 4.53 4.53 10.18 10.94 6.03
Cash Ratio
 0.75 0.75 1.11 3.92 4.81
Solvency Ratio
 0.02 0.02 0.03 0.19 2.98
Operating Cash Flow Ratio
 -0.33 -0.33 0.09 -0.71 6.36
Short-Term Operating Cash Flow Coverage
 -2.19 -2.19 1.37 -165.72 3.28K
Net Current Asset Value
$ 4.83B$ 4.83B$ 10.20B$ 10.72B$ 12.04B
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.06 0.02 <0.01 <0.01
Debt-to-Equity Ratio
 0.11 0.11 0.03 <0.01 0.02
Debt-to-Capital Ratio
 0.10 0.10 0.03 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.06 0.06 0.02 <0.01 <0.01
Financial Leverage Ratio
 1.95 1.95 1.57 1.58 1.80
Debt Service Coverage Ratio
 -0.51 -0.51 -1.42 41.59 1.94K
Interest Coverage Ratio
 -29.67 -29.67 -241.91 -368.72 6.19K
Debt to Market Cap
 1.07 1.07 0.39 0.03 0.03
Interest Debt Per Share
 7.19 7.19 3.02 0.76 1.49
Net Debt to EBITDA
 3.46 3.46 161.08 -22.96 -0.65
Profitability Margins
Gross Profit Margin
67.87%67.87%59.51%54.15%94.47%
EBIT Margin
-75.47%-75.47%-33.63%1.78%90.66%
EBITDA Margin
-48.61%-48.61%-1.34%12.27%91.11%
Operating Profit Margin
-75.47%-75.47%-121.96%-31.22%90.60%
Pretax Profit Margin
-67.90%-67.90%-34.14%1.69%90.65%
Net Profit Margin
-15.46%-15.46%-22.29%7.63%43.70%
Continuous Operations Profit Margin
-51.51%-51.51%-57.63%5.90%74.63%
Net Income Per EBT
22.77%22.77%65.29%451.17%48.21%
EBT Per EBIT
89.97%89.97%27.99%-5.42%100.06%
Return on Assets (ROA)
-0.69%-0.69%-0.73%0.81%50.56%
Return on Equity (ROE)
-0.91%-1.34%-1.15%1.28%90.78%
Return on Capital Employed (ROCE)
-4.11%-4.11%-4.37%-3.58%122.45%
Return on Invested Capital (ROIC)
-3.02%-3.02%-4.34%-3.58%100.70%
Return on Tangible Assets
-0.70%-0.70%-0.73%0.81%50.68%
Earnings Yield
-12.84%-12.84%-15.50%17.69%1317.80%
Efficiency Ratios
Receivables Turnover
 1.23 1.23 0.99 2.45 20.34
Payables Turnover
 7.64 7.64 10.50 34.52 18.30
Inventory Turnover
 1.32 1.32 1.30 3.79 2.86
Fixed Asset Turnover
 0.54 0.54 0.43 1.27 17.87
Asset Turnover
 0.04 0.04 0.03 0.11 1.16
Working Capital Turnover Ratio
 0.05 0.00 0.04 0.13 2.90
Cash Conversion Cycle
 525.82 525.82 613.49 234.83 125.83
Days of Sales Outstanding
 296.04 296.04 367.00 149.03 17.94
Days of Inventory Outstanding
 277.53 277.53 281.26 96.37 127.83
Days of Payables Outstanding
 47.75 47.75 34.77 10.57 19.94
Operating Cycle
 573.58 573.58 648.26 245.40 145.77
Cash Flow Ratios
Operating Cash Flow Per Share
 -7.10 -7.10 1.04 -7.75 154.59
Free Cash Flow Per Share
 -7.78 -7.78 -0.42 -11.80 147.34
CapEx Per Share
 0.68 0.68 1.46 4.05 7.25
Free Cash Flow to Operating Cash Flow
 1.10 1.10 -0.40 1.52 0.95
Dividend Paid and CapEx Coverage Ratio
 -0.14 -0.14 0.22 -1.16 5.91
Capital Expenditure Coverage Ratio
 -10.44 -10.44 0.71 -1.91 21.32
Operating Cash Flow Coverage Ratio
 -1.01 -1.01 0.35 -10.32 105.95
Operating Cash Flow to Sales Ratio
 -1.32 -1.32 0.23 -0.52 0.79
Free Cash Flow Yield
-120.32%-120.32%-6.47%-182.38%2277.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.80 -7.80 -6.10 5.99 0.08
Price-to-Sales (P/S) Ratio
 1.20 1.20 1.44 0.43 0.03
Price-to-Book (P/B) Ratio
 0.10 0.10 0.07 0.07 0.07
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.83 -0.83 -15.46 -0.55 0.04
Price-to-Operating Cash Flow Ratio
 -0.91 -0.91 6.20 -0.84 0.04
Price-to-Earnings Growth (PEG) Ratio
 -0.08 0.00 0.03 -0.06 <0.01
Price-to-Fair Value
 0.10 0.10 0.07 0.07 0.07
Enterprise Value Multiple
 0.98 0.98 54.19 -19.44 -0.61
Enterprise Value
 -184.52M -184.52M -326.69M -3.56B -10.82B
EV to EBITDA
 0.98 0.98 54.19 -19.44 -0.61
EV to Sales
 -0.48 -0.48 -0.73 -2.38 -0.56
EV to Free Cash Flow
 0.33 0.33 7.84 3.03 -0.74
EV to Operating Cash Flow
 0.36 0.36 -3.14 4.62 -0.70
Tangible Book Value Per Share
 87.83 87.83 120.62 126.96 139.31
Shareholders’ Equity Per Share
 61.77 61.77 87.44 89.66 93.92
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 -0.69 -2.49 0.18
Revenue Per Share
 5.37 5.37 4.50 15.00 195.09
Net Income Per Share
 -0.83 -0.83 -1.00 1.14 85.26
Tax Burden
 0.23 0.23 0.65 4.51 0.48
Interest Burden
 0.90 0.90 1.01 0.95 1.00
Research & Development to Revenue
 0.56 0.56 0.77 0.30 <0.01
SG&A to Revenue
 0.87 0.87 1.04 0.55 0.03
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 8.55 8.55 -0.40 -8.75 1.06
Currency in USD